• Explore /
  • Poster
  • / Real-world treatment patterns, testing patterns, and clinical outcomes of first-line (1L) therapy for metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma (mGC/GEJC/EAC).

Real-world treatment patterns, testing patterns, and clinical outcomes of first-line (1L) therapy for metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma (mGC/GEJC/EAC).

Abstract Poster

Authors

null

Sumie Kakehi

Bristol Myers Squibb, Lawrenceville, NJ

Sumie Kakehi , Keith A. Betts , Xiaoyu Nie , Sophie A. Kitchen , Saurabh Ray

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 275)

DOI

10.1200/JCO.2024.42.3_suppl.275

Abstract #

275

Poster Bd #

C13

Abstract Disclosures

Similar Posters

First Author: Mayur Amonkar

First Author: Lin Shen

First Author: Ian Chau

First Author: Lin Shen